Anhui Heryi Pharmaceutical Co (BJSE:920478) Tariff Resilience Score: 0/10 (As of Aug. 24, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BJSE:920478 Anhui Heryi Pharmaceutical Co Ltd BJSE:920478
74 GF Score
Price ¥11.45
GF Value ¥10.44
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Anhui Heryi Pharmaceutical Co Tariff Resilience Score?

Anhui Heryi Pharmaceutical Co has the Tariff Resilience Score of 0, which implies that the company might have .

Anhui Heryi Pharmaceutical Co has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Anhui Heryi Pharmaceutical Co might have .


Anhui Heryi Pharmaceutical Co  (BJSE:920478) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Anhui Heryi Pharmaceutical Co Tariff Resilience Score Related Terms

BJSE:920478
74GF Score
Anhui Heryi Pharmaceutical Co Ltd BJSE:920478
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Anhui Heryi Pharmaceutical Co (BJSE:920478) Overvalued in 2026?

Based on GuruFocus' analysis, Anhui Heryi Pharmaceutical Co stock appears to be overvalued. The current stock price of ¥11.45 is trading 9.7% above its estimated GF Value™ of ¥10.44. GuruFocus considers Anhui Heryi Pharmaceutical Co to be Fairly Valued.

Key valuation signals for BJSE:920478:

  • Tariff Resilience Score: 0
  • GF Value™: ¥10.44 vs. price of ¥11.45 (9.7% above fair value)
  • GF Score™: 74/100 with 5 warning signs

No single metric tells the full story. See the BJSE:920478 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Anhui Heryi Pharmaceutical Co Business Description

Address Yangcun Industrial Park, Anhui Province, Tianchang City, CHN, 239304
Anhui Heryi Pharmaceutical Co Ltd engages in research and development, production, and sales of pharmaceutical intermediates, raw materials, and related products. The main product categories include anti-allergy, anti-thrombosis, anti-oxidation, gastric ulcer, anti-virus, antipyretic and analgesic, and ultraviolet absorbent.
74GF Score

Get the complete analysis for BJSE:920478

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥11.45
Price
¥10.44
GF Value